The facility in Molsheim, France will see increased capacity for the manufacturing of MilliporeSigma’s Mobius single-use assemblies and create 800 jobs.
The €130 million ($131 million) investment, the largest ever in the 50-year history of the site, will significantly increase capacity for Mobius single-use products within the portfolio of Merck KGaA’s life sciences services business – known as MilliporeSigma in North America.
“Molsheim is our largest Life Science campus in France. We have the expertise in-house and the space to build the cleanrooms to manufacture single-use (SU) assemblies. The Molsheim site has unique features that make it the right place to host this activity in Europe,” company spokesman Gangolf Schrimpf told BioProcess Insider.
The Molsheim, France facility. Image c/o Google